• Establishing a New Standard of Care



(click image to enlarge)

HyperMed Imaging’s new product, HyperView™, is a handheld, battery operated, portable diagnostic imaging device that is used to assess tissue oxygenation without contacting the patient. The product is intended for use by physicians and healthcare professionals as a noninvasive tissue oxygenation measurement system that reports an approximate value of oxygen saturation (O2Sat), oxyhemoglobin level (Oxy), and deoxyhemoglobin level (Deoxy) in superficial tissue. The HyperView system displays two-dimensional, color-coded images of tissue oxygenation of the scanned surface. Images and data provide hyperspectral tissue oxygenation measurements for selected tissue regions. The product is indicated for use to determine oxygenation levels in superficial tissues for patients with potential circulatory compromise.

Our pioneering technology was first commercialized by HyperMed Inc. with a prior product called OxyVu™-1, which was FDA cleared in 2006. OxyVu-1 is no longer being produced or sold. It was a cart-based mobile imaging system that has been shown in published clinical research to assess oxyhemoglobin, deoxyhemoglobin and oxyhemoglobin saturation in superficial tissue associated with a number of important healthcare applications including complications associated with vascular compromise, such as wound healing, diabetic foot ulcers, amputation and critical limb ischemia.

HyperMed’s new tissue oximetry device called HyperView™ is FDA 510(k) cleared.
HyperMed, HyperView, OxyVu™-1 and the company logo are trademarks of HyperMed Imaging, Inc.